ContributorsPublishersAdvertisers

Biodesix in pact with PierianDx for lung cancer diagnostics

Seeking Alpha
Seeking Alpha
 2022-01-19
Cover picture for the article

Biodesix (NASDAQ:BDSX) has partnered with PierianDx to improve clinical interpretations for mutations detected by the company’s newly approved GeneStrat NGS genomic test. Accordingly, Biodesix (BDSX) will utilize...

seekingalpha.com

Comments / 0

Comments / 0